John C. Burnett, Ph.D.
Affiliations: | 2002-2008 | Chemical Engineering | University of California, Berkeley, Berkeley, CA, United States |
| 2008-2017 | Molecular and Cellular Biology | Beckman Research Institute of City of Hope, Monrovia, CA, United States | |
| 2017- | Center for Gene Therapy | Beckman Research Institute of City of Hope, Monrovia, CA, United States |
Area:
viral gene delivery, stem cells, HIVWebsite:
https://cal.berkeley.edu/burnettGoogle:
"John C Burnett"Parents
Sign in to add mentor| Adam P. Arkin | grad student | 2008 | UC Berkeley (Chemistry Tree) | |
| (Promoter regulation and stochastic gene expression contribute to HIV-1 proviral latency.) | ||||
| David V. Schaffer | grad student | 2008 | UC Berkeley | |
| (Promoter regulation and stochastic gene expression contribute to HIV-1 proviral latency.) | ||||
| John J. Rossi | post-doc | 2008-2012 | Beckman Research Institute of the City of Hope | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pitchai FNN, Tanner EJ, Khetan N, et al. (2024) Engineered deletions of HIV replicate conditionally to reduce disease in nonhuman primates. Science (New York, N.Y.). 385: eadn5866 |
| Guan M, Lim L, Holguin L, et al. (2022) Pre-clinical data supporting immunotherapy for HIV using CMV-HIV-specific CAR T cells with CMV vaccine. Molecular Therapy. Methods & Clinical Development. 25: 344-359 |
| Li S, Holguin L, Burnett JC. (2022) CRISPR-Cas9-mediated gene disruption of HIV-1 co-receptors confers broad resistance to infection in human T cells and humanized mice. Molecular Therapy. Methods & Clinical Development. 24: 321-331 |
| Chaturvedi S, Vasen G, Pablo M, et al. (2021) Identification of a therapeutic interfering particle-A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance. Cell |
| Holguin L, Echavarria L, Burnett JC. (2021) Novel humanized-PBMC mouse model with delayed onset of GVHD for preclinical HIV research. Journal of Virology. JVI0139421 |
| Shrivastava S, Ray RM, Holguin L, et al. (2021) Exosome-mediated stable epigenetic repression of HIV-1. Nature Communications. 12: 5541 |
| Setten RL, Chomchan P, Epps EW, et al. (2021) CRED9: A differentially expressed elncRNA regulates expression of transcription factor CEBPA. Rna (New York, N.Y.) |
| Arizala JA, Takahashi M, Burnett JC, et al. (2018) Nucleolar Localization of HIV-1 Rev is Required Yet Insufficient for Production of Infectious Viral Particles. Aids Research and Human Retroviruses |
| Satheesan S, Li H, Burnett JC, et al. (2018) HIV replication and latency in a humanized NSG mouse model during suppressive oral combinational ART. Journal of Virology |
| Takahashi M, Wu X, Ho M, et al. (2016) High throughput sequencing analysis of RNA libraries reveals the influences of initial library and PCR methods on SELEX efficiency. Scientific Reports. 6: 33697 |